Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Piperacillin, Tazobactam Drug Combination”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05349305
What this trial is testing

Population Pharmacokinetics of Lassila Tazobactam in Patients After Aortic Dissection

Who this might be right for
Aortic DissectionLung Infection
The Second Hospital of Shandong University 50
Not applicableStudy completedNCT01517815
What this trial is testing

Pharmacokinetic of Doripenem and Piperacillin/Tazobactam in More Than 120 kg Critically Ill Patients

Who this might be right for
Septic Shock
University Hospital, Montpellier 50
Testing effectiveness (Phase 2)Study completedNCT03485950
What this trial is testing

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

Who this might be right for
Other Infectious Diseases
M.D. Anderson Cancer Center 100
Not applicableUnknownNCT03897582
What this trial is testing

Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study

Who this might be right for
Beta-lactamContinuous Renal Replacement TherapyPneumonia+1 more
Centre Hospitalier de Valenciennes 65
Large-scale testing (Phase 3)Study completedNCT02820987
What this trial is testing

PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock

Who this might be right for
Septic Shock
Centre Hospitalier Universitaire de Besancon 119
Post-approval studies (Phase 4)Looking for participantsNCT03671967
What this trial is testing

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Who this might be right for
Beta Lactam Resistant Bacterial InfectionEnterobacteriaceae InfectionsBacteremia
Rambam Health Care Campus 1,084
Large-scale testing (Phase 3)WithdrawnNCT03006679
What this trial is testing

Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

Who this might be right for
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial PneumoniaHospital-Acquired Pneumonia+1 more
Melinta Therapeutics, Inc.
Post-approval studies (Phase 4)Ended earlyNCT00816790
What this trial is testing

Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock

Who this might be right for
Septic ShockAcute Renal Failure
Fraser Health 20
Not applicableStudy completedNCT01714570
What this trial is testing

Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia

Who this might be right for
FebrileNeutropeniaHematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 123
Testing effectiveness (Phase 2)Looking for participantsNCT07481539
What this trial is testing

Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment

Who this might be right for
Bacteria InfectionPiperacillin, Tazobactam Drug Combination
Azienda Sanitaria Universitaria Friuli Centrale 240
Post-approval studies (Phase 4)Study completedNCT02730624
What this trial is testing

Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock

Who this might be right for
Early Phase of Severe Sepsis and Septic Shock
Sutep Jaruratanasirikul 50
Large-scale testing (Phase 3)Study completedNCT03687255
What this trial is testing

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

Who this might be right for
Urinary Tract Infections
Allecra 1,043
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Large-scale testing (Phase 3)Study completedNCT00253955
What this trial is testing

Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia

Who this might be right for
Pneumonia
Sanofi 460
Not applicableUnknownNCT01066013
What this trial is testing

Antimicrobial De-escalation Strategy in Medical Patients

Who this might be right for
Infections
Fraser Health 100
Not applicableStudy completedNCT03850860
What this trial is testing

Comparison of Two Empirical Antimicrobial Therapies of Prosthetic Joint Infection

Who this might be right for
Bone and Joint Infection
Hospices Civils de Lyon 178
Not applicableUnknownNCT04257838
What this trial is testing

Monitoring of Piperacillin-Tazobactam and Meropenem Plasmatic Levels in Critical Patients

Who this might be right for
SepsisSeptic Shock
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 200
Post-approval studies (Phase 4)UnknownNCT04233996
What this trial is testing

Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients

Who this might be right for
Febrile Neutropenia
Hospital Universitari de Bellvitge 150
Large-scale testing (Phase 3)UnknownNCT02191475
What this trial is testing

Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock

Who this might be right for
Abdominal Infection
Tianjin Medical University Cancer Institute and Hospital 100
Not applicableStudy completedNCT00195533
What this trial is testing

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

Who this might be right for
Hematological MalignancyLeukemiaMyelodysplasia+3 more
Wyeth is now a wholly owned subsidiary of Pfizer 801
Next Page